CNC vs LH

Centene Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company shows strong top-line revenue growth of 23.2%, this is completely offset by a catastrophic YoY EPS decline of -248.7% and a deeply negative ROE of -28.68%. The stock appears cheap on a Price-to-Sales (0.12) and Price-to-Book (1.07) basis, but these metrics likely reflect a 'value trap' given the negative profit margins and lack of earnings stability. Despite a recent short-term price rally, the long-term technical trend remains bearish and analyst targets are flat.

Labcorp (LH) presents a mixed profile with a stable Piotroski F-Score of 4/9 and a current price ($259.57) positioned between its defensive Graham Number ($157.1) and growth-based intrinsic value ($308.57). While the company demonstrates strong earnings growth (15.7% YoY) and a highly attractive forward P/E of 13.46, these fundamentals are countered by a bearish technical trend and significant insider selling. The long-term earnings track record is exceptional, but the lack of immediate momentum and mediocre health score suggest a neutral short-term outlook.